| BNF |
British National Formulary |
| CASP |
critical appraisal skills programme |
| CEAC |
cost-effectiveness acceptability curve |
| CGM |
continuous glucose monitoring |
| CI |
confidence interval |
CLOuD
|
closed loop from onset in type 1 diabetes |
| CSII |
continuous subcutaneous insulin infusion |
| CVD |
cardiovascular disease |
| DCCT |
UK diabetes control and complications trial |
| DDS |
diabetes distress scale |
| ESRD |
end stage renal disease |
| FGM |
flash glucose monitoring |
| GRADE |
grading of recommendations assessment, development and evaluation |
| HCHS |
hospital and community health services |
| HCL |
hybrid closed loop |
| HDL:TCL |
high density lipoprotein : total cholesterol levels |
| ICER |
incremental cost-effectiveness ratio |
| iPAG |
Insulin Pump Awareness Group |
| IQR |
inter-quartile range |
| JDRF |
Juvenile Diabetes Research Foundation |
| LY |
life years |
| MD |
mean difference |
| MDI |
multiple daily injections |
| NHSEED |
NHS economic evaluations database |
| NICE |
National Institute for Health and Care Excellence |
| NMA |
network meta-analysis |
| NSHE |
non-severe hypoglycaemic event |
| OR |
odds ratio |
| PAD |
peripheral arterial disease |
| PAID |
problem areas in diabetes |
| PRO |
patient reported outcomes |
| QALY |
quality adjusted life years |
| RCT |
randomised controlled trial |
| RR |
relative risk/risk ratio |
| SCI |
Scottish care information |
| SD |
standard deviation |
| SE |
standard error |
| SHE |
severe hypoglycaemic event |
| SHTG |
Scottish Health Technologies Group |
| SIMD |
Scottish index of multiple deprivation |
| SMBG |
self monitoring blood glucose |
| SUCRA |
surface under the cumulative ranking |
| TBR |
time below range |
| TIR |
time in range |
| UKPDS |
UK prospective diabetes study |
| WESDR |
Wisconsin epidemiological study of diabetic retinopathy |
| WMD |
weighted mean difference |
Scottish Health Technologies Group (SHTG)
